Aktis Oncology

Last updated: September 02, 2025

CEO Matthew Roden
CEO Matthew Roden
USA | Funding: $331M (+)

Website: https://www.aktisoncology.com/

Aktis Oncology develops radiopharmaceutical treatments for solid tumors.




Promote Startup